ABSTRACT Human umbilical endothelial cells (ECs) were grown on fibrillar type I collagen in 16.4-mm multiwell tissue culture plates. Human platelets were added to the wells, and platelet adhesion to collagen was examined by scanning electron microscopy and radioisotopic technique in the absence of ECs and in preconfluent and confluent EC cultures. Single adherent platelets of different shapes as well as small aggregates were seen on collagen surface. Human plasma fibronectin added to the system stimulated platelet adhesion and their spreading on collagen. ECs had no effect on the percentage of platelets adherent to collagencoated gaps in preconfluent culture but decreased the number of spread platelets. It is demonstrated that collagen-coated gaps can bind ' C-labeled liposome.antibody and "'C-labeled liposome-fibronectin conjugates. ECs grown on fibrillar collagen are suggested as useful models for screening of antiplatelet drugs and for the study of drug targeting tothe areas of vascular injury for prevention of thrombosis..
At present, injury of the endothelial lining of the vessel wall is viewed as one of the key mechanisms of thrombogenesis and, possibly, ofatherogenesis (for review, see refs. 1-3). The injury or loss of endothelial cells (ECs) results in the loss of athrombogenic properties by the vessel wall and this leads to adhesion of blood platelets to the injured surface. It is thought that the recognition of injury occurs through a specific interaction of platelets with subendothelium, of which several constituents, particularly collagen, have high affinity toward platelets (1, 2) .
To study the mechanism of platelet adhesion to the injured vessel wall, everted vessel segments or surfaces coated with fibrillar collagen have been used (2, (4) (5) (6) . In the work reported here, an experimental model is described which includes partial reconstitution of the luminal surface of "normal" and "injured" vessel wall. This surface is imitated by a bilayer structure of confluent or preconfluent EC cultures grown on fibrillar collagen. The model was used for: (i) quantitative studies ofplatelet adhesion to collagen-coated gaps in preconfluent EC cultures and to the surface of ECs; (ii) examination of effects produced by plasma fibronectin and ECs on the adhesion and spreading ofplatelets on fibrillar collagen; and (iii) attempts to develop an approach for specific recognition ofcollagen-coated gaps in preconfluent EC culture by "4C-labeled liposome-antibody to type I collagen andd "4C-labeled liposome-fibronectin conjugates.
MATERIALS AND METHODS
Isolation of Fibronectin, Collagen, and Antibodies to Collagen. Human plasma fibronectin was isolated by affinity chromatography on gelatin-Sepharose (7) followed by chromatography on DEAE-cellidlose (8) . Type I collagen was prepared from bovine tendons by extractions with 0.5 M CH3COOH, subsequent multiple reprecipitation with 0.9 M NaCl, and chromatography on DEAE-cellulose (9) . Fibronectin and type I collagen preparations were analyzed by NaDodSO4/polyacrylamide gel electrophoresis (10, 11) 
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were removed, and wells were washed once with 0.2 ml of Tyrode solution. To quantitate platelet adhesion, well bottoms were cut out and 5"Cr radioactivity was measured. To determine the number of adherent platelets by scanning electron microscopy (SEM), 0.2 ml ofTyrode solution containing 2.5% glutaraldehyde (pH 7.3) was added to each well after the removal of nonadherent platelets. The multiwell plate was incubated for 2 hr at 370C, and then each well washed three times with 0.2 ml of 0.15 M NaCl (pH 7.3) and dehydrated with increasing concentrations of ethanol (40% to 100%). Segments of the well bottom were cut out, dried at the critical point, and coated with platinum/palladium. Platelets were counted by using Philips PSEM at x500. Preparation of Liposomes, Protein-Liposome Conjugates, and Binding Studies in EC Cultures. "4C-Labeled liposomes were prepared in 5 mM NaH2PO4/0.01 M Na2B407/0. 145 M NaCl, pH 8.5, with a mixture oflecithin, cholesterol, and phosphatidylethanolamine in the molar ratio 6:2:2 (15).
["4C]Cholesterol oleate (34 Ci/mol, Amersham) was used as a nonexchangeable membrane marker. To prepare the conjugates of "4C-labeled liposome and fibronectin, ,"C-labeled liposome and antibody to type I collagen, and "4C-labeled liposome and nonimmune rabbit IgG, "4C-labeled liposomes were activated with glutaraldehyde (15) and adjusted to a lipid concentration of 1 mg/ml, and protein was added to the liposome suspension to a final concentration of 1 mg/ml. The suspension was incubated overnight at 4°C. Unbound protein was separated from a corresponding conjugate by gel filtration on Sepharose 4B. The protein-to-lipid ratio in the conjugates was 0.1-0.2 mmol of protein per mol of lipid, which corresponds to the binding of 10-20 protein molecules per liposome ofaverage size 1000 A (100,000 molecules oflipid). The specific activity ofliposomes and their conjugates was 4.5 uCi/mg of lipid.
In binding studies, medium 199 (0.5 ml) containing 10% fetal calfserum, 14C-labeled liposome, or 14C-labeled liposome-protein conjugate (approximately 200,000 dpm) was added to each well.
The multiwell plate was incubated for 30 min at 37°C with horizontal rotation (36 rpm). Unbound liposomes were removed, and each well was rinsed twice with 0.5 ml of Tyrode solution. Tightly bound radioactivity was solubilized with two 0.5-ml portions of 10% (vol/vol) Triton X-100; the eluates were pooled and assayed for radioactivity. In each experiment the binding was calculated as the average of six or seven parallel determinations. RESULTS Modeling ofthe Luminal Surface ofthe Vessel Wall. To simulate in vitro the structure of the luminal surface ofa large vessel, ECs were grown in 16.4-mm multiwell tissue culture plates with well bottoms coated with fibrillar type I collagen. After immobilization of the collagen, a dense layer of collagen fibrils formed on the well bottom (Fig. 1A) . For the purpose of this study the collagen layer imitates the subendothelium of a large vessel after extensive denudation.
To simulate the noninjured luminal surface ofthe vessel wall, ECs were grown to confluency on type I collagen. At confluency, the collagen fibrils were completely covered with the monolayer of polygonal ECs (Fig. 1B) . The cell density in confluent culture was about 0.8-1.0 X 105 cells per cm2.
To imitate the luminal surface of the -vessel wall with small focal injuries of endothelial lining, preconfluent EC cultures were used (Fig. 1C) . On days [3] [4] [5] after the seeding, separate single cells as well as cells contacting each other were seen on the collagen surface. These cells covered 30-50% ofthe bottom area. Collagen-coated gaps were seen between individual cells.
Platelet Adhesion. Incubation ofplatelets in wells containing a layer of fibrillar collagen led to platelet adhesion to the collagen surface (Fig. 1D) . The adhesion was dependent on time and dose (Fig. 2) . Under standard experimental conditions, the adhesion reached its plateau after 40 min of incubation. The number of adherent platelets was a linear function of platelet count in the range 1 (Fig. 1E) , platelet adhesion to the surface of ECs was low (0.9 + 0.3 x 103/mm2, mean + SEM; n = 4). This value is approximately 10% ofthe adhesion to fibrillar collagen in the absence of ECs (9.5 + 1.6 x 103/ mm2; n = 7). In the preconfluent cultures the platelets adhered to collagen-coated gaps between cells. The adhesion density in these areas (8.9 ± 2.1 x 103/mm2; n = 4) did not differ from the adhesion to fibrillar collagen in the absence of ECs. The adhesion ofplatelets to the surface ofECs in confluent and preconfluent endothelial cultures was similar (0.9 ± 0.3 x 103/ mm2; n = 3).
By using SEM, one can follow the changes in the shape of platelets during their interaction with collagen-coated surface (Fig. 3) . The initial suspension ofplatelets used in the adhesion experiments contained discs (34 ± 5%), discs with pseudopods (27 ± 5%), spheres (23 ± 5%), and spheres with pseudopods (16 ± 4%) (means ± SEM; n = 8). After 40 min of incubation with the layer of fibrillar collagen, this ratio was drastically changed. The majority of adherent platelets were spheres and discs with pseudopods seen as singles or small aggregates. Discs were found only rarely, some platelets were spread, and thrombi were absent. ' 
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Effects of Fibronectin and ECs on Adhesion and Spreading of Platelets. The addition of human plasma fibronectin to the system containing 5"Cr-labeled platelets and the layer offibrillar collagen stimulated total adhesion ofplatelets to collagen (Table  1) . When 50-200 ,ug offibronectin was added to the incubation mixture, 2-to 3-fold stimulation of adhesion was observed. In the absence of fibronectin, the ratio between spread and nonspread platelets was 1:4. In the presence of this protein, it was 2:3 ( Fig. 4; Table 1 ). Thus, fibronectin stimulates not only the adhesion of platelets to collagen-coated surface but also their spreading.
The shape of platelets adherent to collagen-coated gaps in preconfluent EC culture was altered compared to that observed after adhesion in the absence of ECs (Table 1) : the number of spread platelets was decreased and no effect ofECs on the total adhesion was seen. It is likely that ECs do not affect primary contacts ofplatelets with collagen but rather inhibit the process of platelet spreading. 5.9 x 103 platelets per mm2; n = 6-9. Intact vessel wall as well as various degrees of injury may be imitated by using this model beginning from the loss of 1-10 ECs up to large denudation. Compared to other models used to study platelet adhesion (2, 4-6, 16, 17) our system has a number of specific features including quantitative estimation of adhesion by two independent techniques, the possibility to study platelet adhesion to the cell surfaces, and the possibility to estimate the effect ofcells and various other factors on platelet adhesion and platelet shape.
In the model described, adhesion of platelets occurs under conditions of nonlaminar flow. The study of are formed more actively (1). In our model the kinetic curve of platelet adhesion to fibrillar type I collagen reaches saturation at 40 min of incubation-i.e., later than in a perfusion chamber (2, 18) or in the system with rotating probe (5) . The slowing down of adhesion and the absence of thrombi formation made it possible to visualize various shapes of platelets adherent to the collagen: nonactivated platelet discs, and activated nonspread platelets including discs and spheres with pseudopods and spread platelets. Similar forms of adherent platelets were described in studies ofplatelet interaction with other substrates (19) (20) (21) . It is likely that contact activation of platelets includes two steps: (i) adherent discs are transformed into discs and spheres with protuberances and pseudopods, and (ii) the spreading of platelets occurs. The shape changes of platelets during adhesion may reflect general principles involved in the interaction ofeukaryotic cells with various substrates described by Vasiliev and Gelfand (22, 23) .
Earlier, Hynes et aL (24) demonstrated that plasma fibronectin stimulates platelet adhesion to surfaces coated with collagen. At the same time it has been found that fibronectin inhibits platelet interaction with collagen fibrils in suspension (25, 26) . We have demonstrated that the pretreatment of collagencoated surface with plasma fibronectin stimulates adhesion as well as spreading of platelets. On the other hand, ECs have no effect on the level of platelet adhesion to collagen but inhibit platelet spreading. Because spread platelets are often found at the base of mural thrombi (2), our data may serve as evidence of a possible regulatory function of ECs and plasma fibronectin in the formation of thrombi over injured areas of vascular wall.
The model was used to explore the possibility ofthe liposome targeting to collagen matrix between ECs grown on fibrillar type I collagen. 'It has been found that liposome-antibody to type I collagen and liposome-fibronectin conjugates are selectively bound by collagen matrix between ECs. It is thought that the liposome-carrier conjugates bound by denuded areas of endothelial layer in vivo can function as the microreservoir for a diffusible drug or for enzyme(s) capable oftransforming locally nonactive substrates into pharmacologically active drugs.
In liposome-antibody to type I collagen conjugate the antibody molecule and the surface ofthe liposome are spatially separated and antigen-antibody interaction occurs outside -the liposome surface. Covalent binding of an antibody to the liposome surface (15) or partial embedding of an antibody into the lipid bilayer (27, 28) 
